8. Jan. Aufgabe des FSA ist es insbesondere, für eine korrekte und den Regeln Der FSA-Kodex Fachkreise legt, für die FSA-Mitgliedsunternehmen. Juni Mit dem FSA-Transparenzkodex, der am in Kraft getreten ist, werden zukünftig alle Zuwendungen an Angehörige der Fachkreise. In , the voluntary FSA Codex was adopted by part of the German pharmaceutical industry and was revised several times in the FSA-Kodex Fachkreise.
|Published (Last):||13 February 2009|
|PDF File Size:||7.21 Mb|
|ePub File Size:||2.13 Mb|
|Price:||Free* [*Free Regsitration Required]|
The transparency list with the websites of companies that have published data may be found here. That is why the publication of payments to physicians is now a further logical step”, explains Dr.
DE Contact Members Area. Research-based pharmaceutical companies implement the Transparency Code In June for the first time, the members of the German Association of Research-based Pharmaceutical Companies vfa and FSA published their payments to physicians, healthcare professionals, medical institutions and organizations on their websites.
We have nothing to hide.
By doing so, they upheld their voluntary commitment to implement the Transparency Code. In June for the first time, the members of the German Association of Research-based Pharmaceutical Companies vfa and FSA published their payments to physicians, healthcare professionals, medical institutions and organizations on their websites. In total, the companies paid approx. Click on the image to download the graphic. By implementing the Code of Conduct voluntarily, the member companies of vfa and FSA are creating far-reaching transparency of payments.
Die Eckpunkte des Transparenzkodex
Everyone is in agreement: We have taken the first step by publishing the payments that patient organizations receive from pharmaceutical companies. Overall, the sum total of payments by the 54 koodex to members of the healthcare field for the year amounted to approx. Here is a breakdown of payments by pharmaceutical companies to gachkreise of the healthcare field. On the basis of these figures, the public at large can understand why and how physicians and pharmaceutical companies collaborate”, says Birgit Fischer, Managing Director of vfa.
EUR million, of which EUR million went to physicians and other members of the healthcare field for presentations and further training events, EUR 90 million went to medical organizations and institutions for the sponsoring of events, donations and trusts, and EUR million went to physicians, other healthcare professionals, medical organizations and institutions for conducting clinical studies and observational studies.
Here we have achieved substantive success in removing grounds for unwarranted speculation and thus building up understanding and trust. After the publishing of payments by pharmaceutical companies to physicians, pharmacists and medical institutions, the pharmacist newspaper, “Deutsche Apotheker Zeitung”, spoke with four physicians who received money from pharmaceutical companies last year and asked them why they consented to having their data individually published.